Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques

被引:0
作者
Nobue Kumaki
Hiroshi Kajiwara
Kaori Kameyama
Ronald A. DeLellis
Sylvia L. Asa
R. Yoshiyuki Osamura
Hiroshi Takami
机构
[1] Keio University,Department of Pathology
[2] School of Medicine,Department of Pathology, Rhode Island Hospital
[3] Brown University,Department of Pathology
[4] University of Toronto,Department of Surgery
[5] Teikyo University,Department of Pathology
[6] School of Medicine,undefined
[7] Tokai University,undefined
[8] School of Medicine,undefined
来源
Endocrine Pathology | 2002年 / 13卷
关键词
Pheochromocytoma; paraganglioma; immunohistochemistry; MIB-1; S-100 protein; neuroendocrine marker;
D O I
暂无
中图分类号
学科分类号
摘要
Pheochromocytomas and paragangliomas arise from the adrenal glands and extraadrenal paraganglia, respectively. Malignant behavior of these tumors is uncommon and is, in part, dependent on their sites of origin, such as extraadrenal location. Morphologic criteria for malignancy of pheochromocytoma and paragangliomas have not been clearly defined. In this study, to clarify the histologic features that distinguish the benign from malignant pheochromocytomas and paragangliomas, we examined metastatic and nonmetastatic tumors using immunohistochemical techniques. A total of eight cases, five pheochromocytomas from the adrenal glands (four benign and one malignant tumor) and three paragangliomas with invasion or metastasis, were studied. The markers used in this study were chromogranin A, synaptophysin, NCAM (CD56), SNAP25, neuron-specific enolase, S-100 protein, and MIB-1. Our results suggest that MIB-1 immunostaining is a useful adjunct marker to predict malignant behavior in these tumors.
引用
收藏
页码:149 / 156
页数:7
相关论文
共 90 条
  • [1] Medeiros LJ(1985)Adrenal pheochromocytoma: a clinicopathologic review of 60 cases Hum Pathol 16 580-589
  • [2] Wolf BC(2000)Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases? J Pathol 191 175-180
  • [3] Balogh K(1999)Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas Mod Pathol 12 1107-1111
  • [4] Federman M(1990)Histopathology of benign versus malignant sympatho-adrenal paragangliomas: clinicopathologic studyof 120 cases including unusual histological features Hum Pathol 21 1168-1180
  • [5] Van-der-Harst E(1998)Prognostic makers in pheochromocytoma Hum Pathol 29 522-526
  • [6] Bruining HA(2000)Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein producta, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas Appl Immunohistochem Molecul Morphol 8 267-274
  • [7] Jaap-Bonjer H(1999)Prognostic value of p53, bcl-2 and c-erbB-2 protein expression in pheochromocytomas J Pathol 188 51-55
  • [8] Nagura S(1990)The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas Oncogene 5 1595-1598
  • [9] Katoh R(1997)Expression and prognosis value of c-erbB-2 oncogene product in human pheochromocytomas Histopathology 31 144-149
  • [10] Kawaoi A(1988)Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing Mod Pathol 1 216-223